Rekombinanter Nipah Virus Post-Fusion Glycoprotein (NIV pF) Antikörper

Produktnummer ABIN7824739

Dieser Maus Monoklonal Antikörper erkennt spezifisch in ELISA und WB. Er zeigt eine Reaktivität gegenüber Nipah Virus (NiV).

Kurzübersicht für Rekombinanter Nipah Virus Post-Fusion Glycoprotein (NIV pF) Antikörper (ABIN7824739)

Target: Nipah Virus Post-Fusion Glycoprotein (NIV pF)

Antikörpertyp: Recombinant Antibody

Reaktivität: Nipah Virus (NiV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: ELISA, Western Blotting (WB)

Klon: 3C3

Produktdetails

Expressionssystem: HEK293

Verwendungszweck: Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (3C3) (MALS verified)

Produktmerkmale: Monoclonal Anti-Nipah Post Fusion glycoprotein Antibody, Human IgG1 (3C3) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.

Aufreinigung: Protein A purified / Protein G purified

Reinheit: 95% as determined by SDS-PAGE.

Sterilität: 0.22 μm filtered

Isotyp: IgG1, kappa

Anwendungsinformationen

Applikationshinweise: ELISA: 0.03-16 ng/ml; Western Blot: 0.05-10 µg/ml

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Handhabung: Please avoid repeated freeze-thaw cycles.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: For long term storage, the product should be stored at lyophilized state at -20°C or lower. This product is stable after storage at: -20°C to -70°C for 12 months in lyophilized state; -70°C for 3 months under sterile conditions after reconstitution.

Antigendetails

Target: Nipah Virus Post-Fusion Glycoprotein (NIV pF)

Andere Bezeichnung: Nipah Virus Post-Fusion Glycoprotein

Hintergrund: Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses discovered in the mid-to late 1990s that possess a broad host tropism and are known to cause severe and often fatal disease in both humans and animals. HeV and NiV infect host cells through the coordinated efforts of two envelope glycoproteins. The G glycoprotein attaches to cell receptors, triggering the fusion (F) glycoprotein to execute membrane fusion. G is a type II homotetrameric transmembrane protein responsible for binding to ephrinB2 or ephrinB3 (ephrinB2/B3) receptors. F is a homotrimeric type I transmembrane protein that is synthesized as a premature F0 precursor and cleaved by cathepsin L during endocytic recycling to yield the mature, disulfide-linked, F1 and F2 subunits. Upon binding to ephrinB2/B3, NiV G undergoes conformational changes leading to F triggering and insertion of the F hydrophobic fusion peptide into the target membrane. Subsequent refolding into the more stable post-fusion F conformation drives merger of the viral and host membranes to form a pore for genome delivery to the cell cytoplasm.